Cargando…
Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine
Agomelatine was a novel and melatonergic antidepressant. The present study was conducted to find out whether age was an important factor for agomelatine in treating depressed type 2 diabetes mellitus (T2DM) patients. In total, 193 depressed T2DM patients were included. There were 84 patients ranged...
Autores principales: | Liang, Zihong, Jia, Yanbo, Zhao, Lizhen, Zhu, Runxiu, He, Xuemei, Tong, Bagen, Yang, Fan, Hao, Lixia, Cui, Pengfei, Yuan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544326/ https://www.ncbi.nlm.nih.gov/pubmed/34610580 http://dx.doi.org/10.18632/aging.203586 |
Ejemplares similares
-
Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
por: Kang, Ruiying, et al.
Publicado: (2015) -
Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen, Jian-wei, et al.
Publicado: (2018) -
Discontinuation and dose adjustment of metoprolol after metoprolol‐paroxetine/fluoxetine co‐prescription in Dutch elderly
por: Bahar, Muh. Akbar, et al.
Publicado: (2018) -
Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats
por: Santana, Yanira, et al.
Publicado: (2019) -
Comparison of the treatment efficacies of paroxetine, fluoxetine and dapoxetine in low socioeconomic status patients with lifelong premature ejaculation
por: Balci, Melih, et al.
Publicado: (2019)